132475-93-5

Basic information

• Product Name: 2-Isopropyl-5-nitroaniline
• Synonyms: 2-Isopropyl-5-nitroaniline;Fumarate Impurity 3
• CAS NO: 132475-93-5
• Molecular Formula: C₉H₁₂N₂O₂
• Molecular Weight: 180.20378
• Mol File: 132475-93-5.mol

Chemical Properties

• Appearance: /
• Storage Temp.: Keep in dark place,Inert atmosphere,Room temperature
• CAS DataBase Reference: 2-Isopropyl-5-nitroaniline(CAS DataBase Reference)
• NIST Chemistry Reference: 2-Isopropyl-5-nitroaniline(132475-93-5)
• EPA Substance Registry System: 2-Isopropyl-5-nitroaniline(132475-93-5)

Safety Data

• Hazardous Substances Data: 132475-93-5(Hazardous Substances Data)

Usage

Uses

Used in Dye and Pigment Manufacturing Industry:
2-Isopropyl-5-nitroaniline is used as a key intermediate in the synthesis of dyes and pigments for various applications. Its unique yellow color and chemical properties make it a valuable component in the production of colorants for textiles, plastics, and other materials.
Used in Research and Development:
Due to its chemical structure and properties, 2-Isopropyl-5-nitroaniline is also utilized in research and development for the study of chemical reactions, synthesis processes, and the development of new compounds with potential applications in various industries.

Upstream product

• 643-28-7 2-isopropylaniline 

Downstream Products

• 170230-13-4 5-nitro-2-i-propylphenol 
• 933045-61-5 2-i-propyl-5-(thiazol-2-ylamino)phenol 
• 850085-99-3 5-amino-2-isopropylphenol 
• 936125-95-0 N-(2-isopropyl-5-nitro-phenyl)-acetamide 
• 1356493-40-7 5-fluoro-N₂-(4-isopropyl-3-(1H-tetrazol-1-yl)phenyl)-N₄-(2,2,6,6-tetramethylpiperidin-4-yl)pyrimidine-2,4-diamine 
• 1356493-41-8 2-(4-isopropyl-3-tetrazol-1-yl-phenylamino)-4-(2,2,6,6-tetramethyl-piperidin-4-ylamino)-pyrimidine-5-carboxylic acid amide 
• 1356493-42-9 2-(4-isopropyl-3-(1H-tetrazol-1-yl)phenylamino)-4-(2,2,6,6-tetramethylpiperidin-4-ylamino)pyrimidine-5-carbonitrile 
• 1356493-66-7 4-isopropyl-3-(1H-tetrazol-1-yl)benzenamine 
• 1356493-65-6 1-(2-isopropyl-5-nitrophenyl)-1H-tetrazole 
• 1041186-63-3 C₁₂H₁₇NO₃ 
• 1041186-65-5 C₁₃H₁₉NO₃ 
• 1055233-35-6 C₁₇H₂₁BrN₂O 
• 1041186-75-7 C₁₉H₂₄N₂O₃ 
• 1055233-50-5 C₂₀H₂₅NO₃ 

Relevant articles and documents

PROTEIN KINASE C INHIBITORS AND USES THEREOF

This disclosure concerns compounds which are useful as inhibitors of protein kinase C (PKC) and are thus useful for treating a variety of diseases and disorders that are mediated or sustained through the activity of PKC. This disclosure also relates to pharmaceutical compositions comprising these compounds, methods of using these compounds in the treatment of various diseases and disorders, processes for preparing these compounds and intermediates useful in these processes.

PYRROLOTRIAZINES AS ALK AND JAK2 INHIBITORS

The present invention provides a compound of formula (I) or a salt form thereof, wherein Q1, Q2, Q3, and Q4 are as defined herein. The compound of formula (I) has ALK and/or JAK2 inhibitory activity, and may be used to treat proliferative disorders.

Synthesis of symmetric dinitro-functionalised troeger's base analogues

The synthesis of six new examples of 2,8-dinitro-substituted Troeger's base analogues are reported, together with the first examples of 1,7-, 3,9- and 4,10-dinitro Troeger's base analogues and the first example of a tetranitro Troeger's base compound. Several of these dinitro compounds lack substituents at the 2- and 8-positions and therefore provide further examples of Troeger's base analogues derived from anilines lacking a para substituent.

REXINOID COMPOUND HAVING ALKOXY GROUP

Disclosed is a compound represented by the general formula shown below, which can bind to a retinoid X receptor (RXR), which is one of nuclear receptors, and exhibit an agonistic or antagonistic action. [Wherein, R1 is selected from the group c

COMPOUNDS AND METHODS FOR THE TREATMENT OF VIRUSES AND CANCER

The present invention relates to compounds according to the formula I: Where Ra is H or an optionally OH-substituted C1-C3 alkyl; R1 is OR1, an optionally substituted C4-12 carbocyclic group which may be saturated or unsaturated (including aromatic) or an optionally substituted heterocyclic group; R1 is an optionally substituted C1-C14 hydrocarbyl group or an optionally substituted heterocyclic group;; R2 , R3 and R4 are each independently H, an optionally substituted C1-C4 alkyl group (preferably CH3, CH2CH3 or CF3), halogen (preferably F, Cl, Br), OR, CN, NO2, a C1-C6 thioether, a C1-C6 thioester group, an optionally substituted CO2R group, an optionally substituted COR group or an optionally substituted OCOR group (preferably R4 is H); R is H or an optionally substituted C1-C6 alkyl group; RHET is an optionally substituted heterocyclic group; and pharmaceutically acceptable salts, solvates or polymorphs thereof.

Optimization of diarylamines as non-nucleoside inhibitors of HIV-1 reverse transcriptase

Following computational analyses, potential non-nucleoside inhibitors of HIV-1 reverse transcriptase have been pursued through synthesis and assaying for anti-viral activity. The general class Het-NH-Ph-U has been considered, where Het is an aromatic heterocycle and U is an unsaturated, hydrophobic group. Results for compounds with Het = 2-thiazoyl and 2-pyrimidinyl are the focus of this report.